Expression of resistance markers to methotrexate predicts clinical improvement in patients with rheumatoid arthritis

Por Wolf, J, Stranzl, T, Filipits, M, Pohl, G, Pirker, R, Leeb, B, Smolen, J
Publicado em 2005

Pip2p: a transcriptional regulator of peroxisome proliferation in the yeast Saccharomyces cerevisiae.

Por Rottensteiner, H, Kal, A J, Filipits, M, Binder, M, Hamilton, B, Tabak, H F, Ruis, H
Publicado em 1996

Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing

Por Patton, S, Normanno, N, Blackhall, F, Murray, S, Kerr, K M, Dietel, M, Filipits, M, Benlloch, S, Popat, S, Stahel, R, Thunnissen, E
Publicado em 2014

Dual inhibition of EGFR and mTOR pathways in small cell lung cancer

Por Schmid, K, Bago-Horvath, Z, Berger, W, Haitel, A, Cejka, D, Werzowa, J, Filipits, M, Herberger, B, Hayden, H, Sieghart, W
Publicado em 2010

O6.02 ANALYSIS OF PD1 AND PD-L1 EXPRESSION IN GLIOBLASTOMA

Por Berghoff, A.S., Kiesel, B., Widhalm, G., Wöhrer, A., Dieckmann, K., Filipits, M., Marosi, C., Hainfellner, J.A., Preusser, M., Wick, W.
Publicado em 2014

The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer...

Por Fitzal, F, Filipits, M, Rudas, M, Greil, R, Dietze, O, Samonigg, H, Lax, S, Herz, W, Dubsky, P, Bartsch, R, Kronenwett, R, Gnant, M
Publicado no Br J Cancer (2015)

Expression of ARs in triple negative breast cancer tumors: a potential prognostic factor?

Por Giannos A, Filipits M, Zagouri F, Brandstetter A, Tsigginou A, Sotiropoulou M, Papaspyrou I, Sergentanis TN, Psaltopoulou T, Rodolakis A, Antsaklis A, Dimopoulos MA, Dimitrakakis C
Publicado em 2015-07-01

High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer

Por Zagouri, F, Bago-Horvath, Z, Rössler, F, Brandstetter, A, Bartsch, R, Papadimitriou, C A, Dimitrakakis, C, Tsigginou, A, Papaspyrou, I, Giannos, A, Dimopoulos, M-A, Filipits, M
Publicado em 2013

Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma

Por Ghanim, B, Hoda, M A, Klikovits, T, Winter, M-P, Alimohammadi, A, Grusch, M, Dome, B, Arns, M, Schenk, P, Jakopovic, M, Samarzija, M, Brcic, L, Filipits, M, Laszlo, V, Klepetko, W, Berger, W, Hegedus, B
Publicado em 2014

Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells

Por Hoda, M A, Münzker, J, Ghanim, B, Schelch, K, Klikovits, T, Laszlo, V, Sahin, E, Bedeir, A, Lackner, A, Dome, B, Setinek, U, Filipits, M, Eisenbauer, M, Kenessey, I, Török, S, Garay, T, Hegedus, B, Catania, A, Taghavi, S, Klepetko, W, Berger, W, Grusch, M
Publicado em 2012

EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer

Por Dubsky, P., Filipits, M., Jakesz, R., Rudas, M., Singer, C. F., Greil, R., Dietze, O., Luisser, I., Klug, E., Sedivy, R., Bachner, M., Mayr, D., Schmidt, M., Gehrmann, M. C., Petry, C., Weber, K. E., Kronenwett, R., Brase, J. C., Gnant, M.
Publicado em 2013

The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2− breast cancer patients

Por Dubsky, P, Brase, J C, Jakesz, R, Rudas, M, Singer, C F, Greil, R, Dietze, O, Luisser, I, Klug, E, Sedivy, R, Bachner, M, Mayr, D, Schmidt, M, Gehrmann, M C, Petry, C, Weber, K E, Fisch, K, Kronenwett, R, Gnant, M, Filipits, M
Publicado em 2013

Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study

Por Ghanim, B, Klikovits, T, Hoda, M A, Lang, G, Szirtes, I, Setinek, U, Rozsas, A, Renyi-Vamos, F, Laszlo, V, Grusch, M, Filipits, M, Scheed, A, Jakopovic, M, Samarzija, M, Brcic, L, Stancic–Rokotov, D, Kern, I, Rozman, A, Dekan, G, Klepetko, W, Berger, W, Glasz, T, Dome, B, Hegedus, B
Publicado no Br J Cancer (2015)